Form 4 for TECH Bio-Techne
Accepted 2023-12-21 00:00:00 ET · period of report 2023-12-19 · accession 0001062993-23-023028 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-21 | 2023-12-19 | TECH | Hippel James | CFO | F - Tax | $77.42 | -33.0K | 71.9K | -31% | -$2.55M |
| D | 2023-12-21 | 2023-12-19 | TECH | Hippel James | CFO | M - OptEx | $31.26 | +47.3K | 104.8K | +82% | +$1.48M |
| D | 2023-12-21 | 2023-12-19 | TECH | Hippel James | CFO | M - OptEx | $0.00 | -47.3K | 141.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-19 | F | D | 32,966 | $77.42 | 71,884 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-19 | M | A | 47,289 | $31.26 | 104,850 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2023-12-19 | M | D | 47,289 | $0.00 | 141,867 | D | $31.26 · — to 2024-08-09 | 47,289 Common Stock | (F1) Fully exercisable. |